text_1: 比较 SOLO1 试验 患者 和 PAOLA - 1 试验 BRCA 突变 肿瘤 患者 的 结局 时应 谨慎 , 因为 两项 试验 存在 差异 , 包括 基线 特征 的 差异 ( 表 S3 ) .
  
text_2: caution is needed when comparing outcomes between patients in the SOLO1 trial and patients with BRCA @-@ mutated tumors in the PAOLA @-@ 1 trial because of differences between the two trials , including in baseline characteristics ( Table S3 ) .
  